A new survey, published in The Joint Commission Journal on Quality and Patient Safety, examined insulin pen use in the inpatient setting. Insulin pens can offer several advantages, but there have also ...
Common Sensing, a Cambridge-based company developing a smart connected insulin pen cap, announced that it will test its device in a clinical trial in collaboration with Joslin Diabetes Center, Sanofi, ...
A dedicated clinical program will assess the efficacy of the combined technologies PARIS, FRANCE / ACCESSWIRE / March 21, 2023 / SFD 2023 - Diabeloop, a pioneer in Automated Insulin Delivery, will ...
The FDA has approved Awiqli, the first once‑weekly long‑acting basal insulin, for adults with type 2 diabetes, which offers ...
Novo Nordisk announced today that it received FDA approval for Awiqli, the first and only once-weekly, long-acting basal ...
New insulin products were the go-to choice for U.S. adults with type 2 diabetes in the last half decade, researchers reported. According to a serial cross-sectional study of ambulatory insulin use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results